An Act specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill aims to establish an electronic system in Massachusetts to ensure that the sales of products containing pseudoephedrine (PSE) do not exceed the limits set by federal law. The goal is to help combat the misuse of PSE, which is often used to manufacture illicit drugs. The bill proposes a system to track and regulate these sales more effectively.
Key provisions
- Requires the implementation of an electronic system for tracking PSE sales.
- Ensures sales limits comply with federal regulations.
- The system will be overseen by the Judiciary committee.
- The bill was referred to the Judiciary committee for review.
- A study order (H5281) was associated with the bill.
- The bill was accompanied by a hearing scheduled for July 29, 2025.
- The hearing was rescheduled multiple times.
- The bill was reported by the committee to the Clerk’s Office.
Who is affected
- Pharmacies
- Retailers selling products containing pseudoephedrine
- Individuals purchasing products containing pseudoephedrine
- Law enforcement
- The Massachusetts Judiciary
Notable changes
- The bill focuses on implementing a tracking system to enforce federal limits.
- It builds upon existing federal regulations regarding PSE sales.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours